Satellos Bioscience names new chief medical officer
Source: SeekingAlpha
2025-07-16 07:34:31 ET
Read the full article on Seeking Alpha
For further details see:
Satellos Bioscience names new chief medical officer
Dyne Therapeutics Inc.
NASDAQ: DYN
DYN Trading
-2.56% G/L:
$19.01 Last:
30,246 Volume:
$19.71 Open:
DYN Latest News
March 08, 2026 06:01:00 pm
Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)
DYN Stock Data
$2,792,339,585
138,744,373
0.04%
61
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
